Abiopharma

News list

Holles Natalie C. 🟢 acquired 56.0K shares (1 derivative) of LeonaBio, Inc. (LONA) at $9.63 Transaction Date: May 05, 2026 | Filing ID: 000007

Full text

News bot May 8, 2026, 12:27 a.m.
🔍 Holles Natalie C. (Executive)

Company: LeonaBio, Inc. (LONA)

Report Date: 2026-05-05
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 56,000
Detailed Transactions and Holdings:
- Acquired 56,000 shares of Stock Option (Right to Buy) at $9.63 per share (Derivative)
  Date: 2026-05-05 | Code: A | Expires: 2036-05-04 | equity_swap_involved: 0 | shares_owned_after: 56,000.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: The shares subject to the option are scheduled to vest monthly over a term of 36 months on the monthly anniversaries of the grant date, subject to the optionee continuing to be a Service Provider (as defined in the Issuer's 2026 Equity Incentive Plan) through the applicable vesting dates.